IVERIC bio, Inc.

IZERVAY

Manufacturer:

IVERIC bio, Inc.

Izervay HCPCS:

C9162

HCPCS Code Descriptor:

Injection, avacincaptad pegol, 0.1 mg

Category:

C Code

Izervay NDCs:

82829-0002-01

Primary Type:

Opthalmic

Generic/Specialty Status:

Single-Source

Route of Administration:

Intraocular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Izervay:

IZERVAY is an Opthalmic drug manufactured by IVERIC bio, Inc. and administered via the Intraocular route of administration. The C Code: C9162 is aligned to the drug IZERVAY.

Izervay is an injection used to treat geographic atrophy, or GA, caused by age-related macular degeneration. GA can lead to irreversible vision loss. Izervay is used to slow the progression of the disease, allowing patients to maintain vision for longer. Izervay works by helping to block the immune system from destroying healthy cells in the eye.

ACCESS PRICING AND MORE BY REGISTERING

C9162 Added Date:

January 1, 2024

C9162 Effective Date:

January 1, 2024

C9162 Termination Date:

HCPCS Active

Izervay billing and coding information can be found through Iveric Bio, Inc. at the link below:
Izervay patient assistance information can be found through IZERVAY My Way at the URL: https://www.izervayecp.com/access-support
IZERVAY prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for IZERVAY. Please check back in a few weeks.